Articles related to GLP-1 RECEPTOR AGONISTS

Blood thinners interact with various medications and supplements, potentially increasing bleeding risk or reducing efficacy. Physicians should be aware of these interactions and educate patients on the importance of consulting healthcare professionals before taking new products.

Semaglutide may alter taste perception gene expression in the tongue and modify brain reactions to sweet tastes, potentially enhancing weight loss effects beyond appetite suppression.

Patients taking semaglutide for diabetes were more than four times more likely to develop NAION compared to those on other diabetes medications, while those using it for obesity had a seven-fold increased risk.

Rapid weight loss from semaglutide use can lead to breast ptosis, mirroring effects seen after bariatric surgery. Healthcare providers should be prepared to counsel patients on this potential outcome and offer strategies for management.

A diet high in soluble fiber, protein, and healthy fats can mimic the effects of GLP-1 agonists like Ozempic, offering a safer alternative for weight management and metabolic health.

GLP-1 receptor agonists, beyond their role in diabetes and obesity management, are showing promise in reducing alcohol cravings, potentially offering a novel approach to treating alcohol use disorder.